CD274 and neoplasm: Exploratory analyses were conducted to evaluate the associations between PD-L1 expression, tissue tumor mutation burden (TMB), and mismatch repair (MMR) gene status to clinical responses of toripalimab in combination with gemcitabine and 5-fluorouracil (5-FU).